• Her journey from high school dropout to certified pharmacy technician and compounding leader
• Transitioning from retail pharmacy (Walgreens) to specialty compounding

• Leading non-sterile compounding operations at one of the fastest-growing pharmacies in the country

• Quality assurance: triple-checking processes, USP 795/800 compliance, and minimum weighable quantities

• Creating custom formulations including suppositories, capsules, topical compounds, and rapid-dissolve tablets

• Why "just a technician" doesn't exist—and the expanding scope of pharmacy technician practice

• Staying current with continuing education through PCCA, APhA, NPTA, and industry newsletters

• Her memorable patient impact story: creating a custom prednisone tablet troche for a pediatric patient

• Why the 2002 Women's Health Initiative study was flawed and created decades of HRT concerns
• The timing hypothesis: why age matters when starting hormone replacement therapy
• Synthetic vs. bioidentical hormones and their clinical differences
• Oral estrogen delivery systems and safety implications
• Shared decision-making between patients, prescribers, and pharmacists
• Why compounded HRT solutions matter for patients who don't fit commercial products
• Hormone testing modalities and why multiple testing methods are essential
• Vaginal estrogen's role in preventing UTIs and hip fractures
• How pharmacists can educate providers and patients on HRT safety

In this episode of a Mortar and Pestle, Tenille Davis, Chief Advocacy Officer for the Alliance for Pharmacy Compounding, joins host Mike De Lisio and guest co-host Erin Michael, Director of Member Engagement, to discuss the APC Blue Print, a blueprint for eliminating redundant, unauthorized, or ineffective regulation that impedes patient access to compounded drugs.

In this episode of a Mortar and Pestle, Vice President of Research and Development Daniel Banov and Senior Formulation Specialist Courtaney Davis join host Vice President of North American Sales Mike De Lisio and co-host Clinical Compounding Pharmacist, RPh, FAARM (Candidate) Sebastian Denison, to discuss PCCA’s newest base innovation, UniFlow ­— a game changer in T3 and T4 compounding.

In this episode of a Mortar and Pestle, Tricia Heitman, PharmD, joins host Mike De Lisio, Vice President of North American Sales, and co-host Sebastian Denison, Clinical Compounding Pharmacist, RPh, FAARM (Candidate) to discuss leucovorin and other supplements for autism.

In this episode of The Mortar & Pestle Podcast, pharmacist and hormone therapy expert Ranel Larsen joins Mike de Lisio, Vice President of North American Sales, and Sebastian Denison, Clinical Compounding Pharmacist, RPh, FAARM (Candidate), to dig into men’s health. From hormone replacement therapy and lab testing to lifestyle factors like stress, sleep, and nutrition, Ranel breaks down how pharmacists can better support male patients while debunking common myths around testosterone.

In this special live episode of Tech Talk, a Mortar & Pestle production, Erin Michael, Director of Member Engagement, is joined by Tiffany Kofroth, CSPT, CPhT-Adv, Advanced Pharmacy Technician in Continuing Pharmacy Education at the University of Texas at MD Anderson Cancer Center from and Mindy Stephens, as they discuss their compounding journeys.